EXAC Exactech, Inc.

New Studies Support Exactech’s Knee, Shoulder and Computer-Assisted Surgery Technologies

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder and spine, today reported that studies involving its knee and shoulder joint replacement innovations and its ExactechGPS® guided personalized surgery system were featured at the 29th Congress of The International Society for Technology in Arthroplasty (ISTA) in Boston, Massachusetts.

The studies presented by orthopaedic surgeons and Exactech engineers and scientists included a presentation, “Benefit of Modern Navigation System in Total Knee Arthroplasty" by Jung-Dong Chang, MD, PhD, who was honored as an ISTA Invited Faculty member from South Korea. His study of 272 total knee replacement surgeries using the Optetrak Logic® knee system, supported by the ExactechGPS computer-assisted surgery system, demonstrated accurate and reproducible results in terms of joint implant alignment and implant position.

Additional studies featuring Exactech technologies include the following:

Shoulder Arthroplasty

Impact of Radiolucent Glenoid Lines on Clinical Outcomes in Anatomic Total Shoulder Arthroplasty

Christopher Roche; Alexander Greene; Thomas Wright, MD; Pierre Henri Flurin, MD; Joseph Zuckerman, MD; Sean Grey, MD

Impact of Radiolucent Humeral Lines on aTSA Clinical Outcomes for Cemented and Noncemented Humeral Stems

Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD; Richard Jones, MD

Rate of Improvement in Clinical Outcomes with Anatomic and Reverse Total Shoulder Arthroplasty

Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD; Ryan Simovitch, MD

A Comparison of Clinical Outcomes With Anatomic and Reverse Total Shoulder Arthroplasty at Midterm Followup

Christopher Roche; Alexander Greene; Pierre Henri Flurin, MD; Thomas Wright, MD; Joseph Zuckerman, MD

Knee Technologies & Surgical Techniques

Benefit of Modern Navigation System in Total Knee Arthroplasty

presented by ISTA invited faculty member Jun-Dong Chang, MD, PhD

Impact of the Tibial Alignment Method on Accuracy of Resection Planning During TKA

Laurent Angibaud; Yifei Dai; Matthew Rueff; Michael B. Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD; Amaury Jung

Passive Reception of Feedback Does Not Improve the Accuracy of Resection Planning During TKA

Yifei Dai; Laurent Angibaud; Matthew Rueff; Michael B.Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD; Amaury Jung

Impact of Experience on the Execution of Tibial Resection Planning During TKA

Matthew Rueff; Laurent Angibaud; Yifei Dai; Michael B. Cross, MD; Kyle Swanson, MD; Matthew Crozier, MD; Brendan Williams, MD, MD; Amaury Jung

Computer-Assisted Surgery

Total Knee Arthroplasty Using a Contemporary Computer-Assisted Surgical System: A Review of Surgical Parameters on More Than 4000 Clinical Cases

Yifei Dai; Fabrice Bertrand; Laurent Angibaud; Cyril Hamad; Amaury Jung; David Liu, MD; James Huddleston, MD; Bernard Stulberg, MD

Novel CT Based Cadaveric Validation of the Accuracy of a Computer Navigated Surgery System

Alexander Greene; Matthew Hamilton; Sandrine Polakovic; Richard Andrews; Richard Jones, MD; Ira Parsons, MD; Paul Saadi,MD; Emilie Cheung, MD; Pierre Henri Flurin, MD; Thomas Wright, MD

Geographic Variations in the Surgical Profiles of Computer-Assisted Total Knee Arthroplasty

Yifei Dai; Laurent Angibaud; Amaury Jung; Cyril Hamad; Fabrice Bertrand; James Huddleston, MD; Bernard Stulberg, MD

Computer-Assisted Total Knee Arthroplasty: Impact of Surgeon Experience on the Ability to Achieve Surgical Resection Goals

Yifei Dai; Laurent Angibaud; Amaury Jung; Cyril Hamad; Fabrice Bertrand; Bernard Stulberg, MD; James Huddleston, MD

About ISTA

The International Society for Technology in Arthroplasty (ISTA) is a nonprofit corporation whose goal is to promote public awareness, education and research, in arthroplasty. The means by which this purpose is achieved is through ISTA’s Annual Congress where emerging technologies are discussed between surgeons, engineers, and industry.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at http://www.exac.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

EN
12/10/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Exactech, Inc.

 PRESS RELEASE

Exactech Announces Completion of Merger with TPG Capital

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, is pleased to announce the successful completion of the previously announced merger agreement with TPG Capital, pursuant to which TPG has acquired all of the issued and outstanding common stock of Exactech. In connection with the transaction, Exactech shareholders will receive $49.25 in cash for each share of Exactech common stock they hold (o...

 PRESS RELEASE

Exactech Shareholders Approve Merger Agreement with TPG Capital

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at a Special Meeting of Shareholders held earlier today, Exactech’s shareholders approved the previously announced merger agreement with TPG Capital and certain of its affiliates, and approved the other two proposals described in Exactech’s proxy statement relating to today’s meeting. Approximately 94.5% of voting Exact...

 PRESS RELEASE

EXACTECH (EXAC) INVESTOR ALERT - Andrews & Springer LLC is Seeking Mor...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...

 PRESS RELEASE

EXACTECH (EXAC) SHAREHOLDER ALERT - Andrews & Springer LLC is Seeking ...

WILMINGTON, Del.--(BUSINESS WIRE)-- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Exactech, Inc. (NASDAQGS: EXAC) (“Exactech” or the “Company”) relating to the sale of the Company to affiliates of private equity firm TPG Capital (“TPG”). On December 4, 2017, the two parties announced the signing of an amended merger agreement pursuant to which TPG will acquire Exacte...

 PRESS RELEASE

Exactech Announces Successful First Surgery with Vantage ® Total Ankl...

GAINESVILLE, Fla.--(BUSINESS WIRE)-- Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products for extremities, hip, and knee, announced today the successful first surgery using its new Vantage® Total Ankle Mobile Bearing System, the newest addition to the Exactech extremities product line. Orthopaedic surgeon and Vantage Ankle design team member Professor Victor Valderrabano, MD, PhD, chairman of the Swiss Ortho Center Basel, recently performed the first case in the world with the mobile, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch